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Long noncoding RNAs (lncRNAs) are potentially important regulators of cell 
differentiation and development, but little is known about their roles in B-lymphocytes. 
Using RNA-seq and de novo transcript assembly, we identified 4516 lncRNAs 
expressed in 11 different stages of B cell development and activation. Most of these 
lncRNAs have not been previously detected, even in the closely related T cell 
lineage. Comparison with lncRNAs previously described in human B cells identified 
185 mouse lncRNAs that have human orthologues. Using ChIP-seq we classified 
20% of the lncRNAs as either enhancer-associated (eRNA) or promoter-associated 
(pRNA) RNAs. We identified 126 eRNAs whose expression closely correlated with 
the nearest coding gene, thereby indicating the likely location of numerous 
enhancers active in the B cell lineage. Furthermore, using this catalogue of newly 
discovered lncRNAs we show that PAX5, a transcription factor required to specify the 
B cell lineage, bound to and regulated the expression of 109 lncRNAs in pro-B and 
mature B cells and 184 lncRNAs in acute lymphoblastic leukemia. 
  




Long noncoding RNAs (lncRNAs) have emerging roles in innate and adaptive 
immunity. For example, lnc-DC is required for normal dendritic cell differentiation and 
function1, IL1β-eRNA and IL1β-RBT46 are required for LPS-induced pro-
inflammatory responses in monocytes2, and NRAV modulates cellular responses to 
viral infections3. In T cells, an intronic lncRNA NRON abrogates the nuclear transport 
of NFAT, and hence modulates expression of IL-24. In B cell lymphomas, the lncRNA 
Fas-AS1 modulates expression of soluble Fas receptor mRNA, an important 
regulator of apoptosis5. Thus lncRNAs have the potential to influence both normal 
and pathological immune cell development and function.  
 
LncRNAs may operate via a variety of molecular mechanisms6. For example, 
enhancer-associated lncRNAs (eRNAs) act in cis and originate from transcribed 
extragenic or intragenic enhancer regions, whereas promoter-associated lncRNAs 
(pRNAs) can act in trans and originate from canonical promoter-derived 
transcriptional activity7,8. These two broad lncRNA categories are distinguished by 
the ratio of mono- versus tri-methylation of histone 3 lysine 4 (H3K4me1/3)8. 
Compared with pRNAs, eRNAs tend to exhibit more restricted expression and their 
RNA sequences show less constraint8. 
 
Advances in sequencing technology have enabled the identification of large numbers 
of putative lncRNA loci9,10. However, the proportion of lncRNAs with clearly defined 
function is small11,12, caused in part by poor annotation of lncRNAs expressed in a 
tissue of interest, making it difficult to select candidate lncRNAs for targeted studies. 
This is a consequence of the expression patterns of lncRNAs which are often 
restricted to one, or very few tissues or cell types9. Recent studies have addressed 
this limitation by surveying lncRNA expression in a number of organisms and 
tissues13-17, including murine T cells18. However, there have been no comparable 
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attempts to use sequencing technologies to describe the murine B cell lncRNA 
repertoire.  
 
To facilitate the study of lncRNA biology in B cells, we describe here a catalogue of 
4516 de novo assembled high-confidence lncRNAs expressed in 11 mouse B cell 
populations. We identify human lncRNAs that may be orthologues of the mouse 
genes. Furthermore, we classify subsets of eRNAs and pRNAs, and perform an 
unsupervised clustering analysis to associate lncRNAs with mRNAs at key stages of 
B cell development. Finally, we utilize the lncRNA catalogue to show that PAX5, a 
transcription factor required to specify the B cell lineage19, binds to and regulates 
expression of lncRNA loci in both pro-B and mature B cells, as well as in acute 
lymphoblastic leukemia. 
 
MATERIALS AND METHODS 
Mice 
All RNA-seq and ChIP-seq experiments were performed with female C57BL/6JNimr 
mice aged 7-9 weeks, except for RNAseq of plasmablasts and plasma cells which 
were obtained from 12-14 week old Blimp1-GFP mice20. 
 
Cell Sorting 
Gating strategies for cell sorting are shown in Supplemental Figure 1. 
 
RNA-seq 
Sorted populations of cells were re-suspended in Trizol (Life Technologies), and RNA 
was purified using the RNeasy Mini Kit (Qiagen). RNA quality was assessed using 
the 2100 Expert Agilent Bioanalyser. For all samples except plasmablasts and 
plasma cells, stranded polyA-enriched libraries were made using the Stranded 
TruSeq RNA Sample Preparation Kit (Illumina) and sequenced on the HiSeq 2500 
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(Illumina), collecting 100 base paired-end reads. For plasma cells and plasmablasts, 
unstranded non-rRNA-enriched libraries were made using the SMARTer Ultra Low 
Input RNA Kit for Sequencing v3 (Clontech) and sequenced collecting 50 base 
paired-end reads. All RNA-seq and ChIP-seq data (see below) has been deposited at 
NCBI Gene Expression Omnibus (accession number GSE72019). 
 
ChIP-seq 
Chromatin immunoprecipitation-sequencing was performed in triplicate for all stages 
of B cell development, except plasmablasts and plasma cells, as described 
previously21. For details see Supplemental Methods. 
 
RNA-seq read alignment and transcript assembly 
RNA-seq reads were aligned to the C57BL/6J mouse reference genome (mm10, 
GRCm38) using STAR22 v2.3.0e. Transcript assembly was performed separately for 
all samples except plasmablasts and plasma cells using Cufflinks23 v2.2.0. Non-
uniquely mapping reads were retained during assembly and potential transcripts 
(transfrags) were discarded when they contained fewer than five successfully 
mapped reads. Individual assemblies were subsequently compared and transfrags 
were discarded if they were not assembled in at least two samples.  
 
Identification of long non-coding RNAs 
The lncRNA discovery pipeline is depicted in Supplemental Figure 2A. Following 
assembly, transcripts <200bp in length were discarded. Remaining transcripts were 
filtered against existing databases (Ensembl v72 and NCBI RefSeq), and discarded if 
they intersected (>=1bp, on the same strand) intervals annotated as anything other 
than non-coding RNA. Transcripts were also discarded if they were found to intersect 
nuclear mitochondrial DNA (Numts) or pseudogenes predicted using Exonerate24, if 
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they were in close proximity downstream of a protein coding gene, or if they were 
classified as coding by both Coding Potential Calculator25 and PhyloCSF26. Further 
details, including a description of lncRNA nomenclature, are provided in 
Supplemental Methods. LncRNAs classed as intergenic (>5kb from a protein-coding 
gene) were identified as eRNAs or pRNAs using H3K4me1 and H3K4me3 ChIP-seq 
data in conjunction with a stringent classification pipeline (Supplemental Figure 2B), 
in which successfully classified loci were required to intersect a called chromatin 
peak and to show four-fold greater coverage of reads arising from their characteristic 
chromatin mark. 
 
UCSC public hub 




4516 lncRNA loci expressed during B cell development  
In order to identify and characterize lncRNAs expressed during B cell development 
and activation, we used fluorescence-activated cell sorting to obtain 5 replicate cell 
samples for each of 8 purified B cell populations derived from the bone marrow, 
spleen, and peritoneal cavity of adult female C57BL/6JNimr mice (Figure 1A, 
Supplemental Figure 1A-D). These populations represent the major subsets of 
developing B cells in the bone marrow (pro-B cells, pre-B cells and immature B cells) 
and subsets of mature B cells in the bone marrow, spleen (follicular and marginal 
zone B cells), and peritoneal cavity (B1a cells). In addition we also sorted germinal 
center (GC) B cells, an activated B cell subset. From each of these 40 samples we 
extracted and sequenced the polyA+ RNA fraction in a strand-specific manner to an 
average depth of 42 million uniquely mapped reads, using a 2x100 base paired-end 
sequencing protocol. 




To identify lncRNAs we used a de novo transcript assembly pipeline (Supplemental 
Figure 2A). Stringency of selection of potential lncRNA loci was assured by 
discarding transcripts whose assembly was not replicated in at least 2 of the 40 
sample libraries, by discarding loci represented in public databases of protein-coding 
annotations (ENSEMBL & RefSeq), and by discarding loci containing transcripts with 
predicted coding potential (Supplemental Figure 3A-C). Using this process we 
identified 4516 lncRNA loci that were expressed in at least one of the 8 B cell 
populations, and comprised, on average, 1.8 transcripts per locus (Supplemental 
Table 1). To validate the assembly process, we used PCR to check for expression of 
predicted lncRNAs. Of 53 lncRNAs with expression values ranging between 0.9 and 
667 FPKM, we were able to successfully validate 47 (89%), demonstrating that the 
assembly pipeline had generated reliable transcripts (Supplemental Figure 4). 
 
Of the predicted lncRNA loci, 3025 (67%) showed no evidence of splicing (single-
exon loci), whereas the remaining 1491 showed evidence of at least one spliced 
transcript (multi-exon loci). Approximately half of all single and multi-exon loci were 
intergenic, with the remainder being either flanking (<5kb from a protein-coding gene) 
or overlapping a protein-coding gene on the antisense strand (Figure 1B, 
Supplemental Table 2). The single-exon and multi-exon lncRNAs showed similar 
coding potential, expression levels and mean exon sizes, supporting the view that 
they belong to the same gene class (Supplemental Figure 5A-D). 
 
Intergenic B cell lncRNAs show little overlap with existing lncRNA catalogues 
We compared the 2349 intergenic lncRNA loci identified in this study with intergenic 
lncRNAs reported in mouse T cell subsets18, and with the latest Ensembl (v74) long 
intergenic non-coding RNA (lincRNA) annotations. 1829 (78%) of the intergenic 
lncRNAs in our B cell catalogue did not overlap on the relevant strand with either the 
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T cell or Ensembl lincRNAs (Figure 1C), reinforcing the notion that many lncRNAs 
are tissue- or cell type-specific in their expression9,12,18. 
 
The highly tissue-specific expression of B cell lncRNAs was further confirmed by 
comparison of our catalogue with the FANTOM5 study of transcriptional start sites 
(TSS) in 128 mouse primary cell types27, which included a single B cell sample. As 
FANTOM annotation required a TSS to be detected in two or more samples, we did 
not expect this dataset to include TSS for lncRNAs expressed only in B cells. 
Accordingly, only 299 (13%) of our intergenic lncRNAs were within 500bp of a 
FANTOM annotated TSS (Figure 1D,E). Notably, a greater overlap with FANTOM 
annotated TSS was observed for multi-exon transcripts than for single-exon 
transcripts. The same trend was observed in comparisons with previous lncRNA 
annotations (Supplemental Figure 5E,F). We therefore conclude that expression at a 
lncRNA locus is more likely to be recapitulated in different cell types if the locus 
contains evidence of splicing. 
 
A previous study had shown that many lncRNAs overlap with transposable elements 
(TEs)28. In agreement with this, we find that around 40% of the lncRNAs identified 
here overlap with TEs, and a comparison of these with the genomic content of TEs 
shows an enrichment of endogenous retroviruses and a relative depletion of LINE 
elements, similar to the previous report (Figure 1F, Supplemental Table 3). 
 
In summary, we have generated a novel, high-confidence catalogue of lncRNAs 
expressed across key stages of B cell development. To facilitate the use of this 
catalogue, we have visualized our genomic data as a UCSC public hub, which can 
be accessed at 
https://www.cgat.org/downloads/public/projects/proj010/UCSC_track_hub/hub.txt.  
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Chromatin signatures identify intergenic lncRNAs with enhancer-associated 
and promoter-associated expression  
In order to identify intergenic lncRNAs within our catalogue that may be either eRNAs 
or pRNAs, we determined the genome-wide abundance of H3K4me1 and H3K4me3 
chromatin marks known to distinguish these two lncRNA subtypes8 (Figure 2A,B). 
We quantified the relative abundance of these marks at the proposed TSS of 2349 
intergenic lncRNAs across all 8 B cell populations, and identified eRNAs and pRNAs 
using stringent selection criteria (Supplemental Figure 2B). 
 
702 eRNAs and 192 pRNAs were predicted in one or more B cell populations (Figure 
2C, Supplemental Figure 6A-C, Supplemental Table 2), and were evenly distributed 
between single-exon (320 eRNAs, 96 pRNAs) and multi-exon loci (382 eRNAs, 96 
pRNAs, Figure 2D). H3K4me1 and H3K4me3 marks at all lncRNA loci remained 
broadly consistent across B cell populations (Figure 2E). Furthermore, lncRNA 
classified as eRNAs or pRNAs in one B cell population displayed a comparable 
chromatin signature in other cell populations (Supplemental Figure 6D,E), suggesting 
that these classifications represent two largely mutually-exclusive lncRNA classes.  
 
In agreement with earlier studies8, B cell eRNAs were distinguishable from pRNAs by 
a significantly higher correlation of expression with their proximal protein-coding gene 
(Figure 2F), by lower expression (Fig 2G), and by expression in fewer cell subsets 
(Figure 2H). Thus lncRNAs with a high H3K4me1:H3K4me3 ratio at their TSS show 
characteristics typical of eRNAs and their expression tends to be associated with the 
expression of adjacent protein-coding genes. 
 
LncRNAs are expressed at discrete stages during B cell development 
Previous studies in the T cell lineage had shown that intergenic lncRNA expression is 
highly restricted even between closely related T cell subsets17,18. If this were also the 
case for B cells, then B cell subsets should be distinguishable on the basis of lncRNA 
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expression. Indeed, using both hierarchical clustering and principal component 
analysis on either coding gene or lncRNA expression, all 8 B cell populations were 
distinguishable and replicate samples clustered closely (Figure 3A,B, Supplemental 
Figure 7A-D). For both types of genes, follicular and marginal zone B cells were the 
most closely related, whereas B1a cells and GC B cells showed the greatest 
distinction from other cell types. 
 
A greater proportion of B cell lncRNAs were differentially expressed between cell 
populations than protein-coding genes (Supplemental Figure 8A). Whilst cell type 
specificity was, as expected, dependent on expression level, even at equivalent 
expression levels, lncRNAs displayed greater cell-type restriction than coding genes 
(Figure 3C, Supplemental Figure 8B,C), suggesting that lncRNAs have very 
restricted spatio-temporal roles during B cell development. 
 
The trend for lncRNAs to be more restricted in expression than protein-coding genes 
was observed across all stages of B cell development. At a defined expression 
threshold (FPKM>1), a greater proportion of protein-coding genes than lncRNAs 
were expressed in all bone marrow-derived B cell populations, in all splenic and 
peritoneal cavity mature B cell populations, and in both naïve and activated B cell 
populations (Figure 3D,E). 
 
To extend this analysis further we examined expression of the lncRNAs in antibody-
secreting cells. We performed RNA-seq on splenic plasmablasts and plasma cells 
and on bone marrow plasma cells (Supplemental Figure 1E,F Supplemental Figure 
7E) and determined expression of lncRNAs and coding genes in these three 
additional subsets (Supplemental Table 2). Principal component analysis showed 
that the 3 subsets clustered closely together (Supplemental Figure 7F,G) and 
lncRNAs were again more cell type-specific (Figure 3D,E). 




Generating hypotheses for lncRNA functions through correlation with protein-
coding gene expression 
One genome-scale approach to generate hypotheses regarding lncRNA function is to 
exploit a ‘guilt by association’ approach by correlating expression of lncRNAs with 
coding genes of known biological function9,29. We predicted the biological processes 
to which lncRNAs might contribute by clustering protein-coding loci expressed in at 
least one B cell type (median FPKM>1) into one of 17 clusters, based on correlation 
of expression across B cell development30 (Supplemental Figure 9A,B, Supplemental 
Table 2). We subsequently correlated individual lncRNAs with the representative 
gene expression profile (eigengene) for each protein-coding cluster (Figure 4A), and 
defined an association between a lncRNA and a cluster of protein-coding genes at a 
Pearson correlation coefficient of |ρ| > 0.8 (Figure 4B). At this threshold, 987 (22%) 
lncRNAs associated with protein-coding gene clusters, suggesting that these 
lncRNAs contribute to the same biological processes as the protein-coding genes 
within the respective cluster. While some clusters were characteristic of individual cell 
stages (Figure 4A), Gene Ontology enrichment analysis31 identified others that were 
associated with cellular processes (Supplemental Table 4). For example the 
lightpink4 cluster contains genes up- or down-regulated in MZ B cells, whereas the 
floralwhite cluster is enriched for genes associated with the cell cycle, and its 
eigengene is highest in pro-B cells, pre-B cells and GC B cells, the 3 subsets with the 
highest rates of cell division. 
 
We previously showed an increased correlation of expression between eRNAs and 
their proximal protein-coding gene compared to pRNAs (Figure 2F), and the 
association of lncRNAs with clusters of protein-coding genes allowed us to test this 
hypothesis further. Permutation tests demonstrated that eRNAs showed strongest 
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correlation with the cluster containing their proximal protein-coding gene (p = 0.04), 
whilst no such trend was observed for pRNAs (p = 0.51).  
 
Combining information about genomic location, chromatin state, and expression 
allowed us to identify eRNAs that may function in cis with genes of distinctive 
biological function. For example, Figure 4C shows a single cluster of protein-coding 
genes that exhibit large changes of expression within marginal zone B cells. Of the 
lncRNAs correlated with this cluster, we show one (LNCGme02323) that is proximal 
to cluster member Zc3h12c, encoding a zinc finger protein implicated in the 
regulation of pro-inflammatory activation in macrophages32. Using our catalogue, 
LNCGme02323 is identifiable as an eRNA that is co-expressed with Zc3h12c in 
marginal zone B cells, and which lies ~67 kb upstream of the coding gene TSS 
(Figure 4D,E), suggesting that this lncRNA may be transcribed from an enhancer 
controlling the expression of Zc3h12c. In total we were able to identify 126 eRNA loci 
whose expression was most strongly correlated with that of a WGCNA module 
containing an adjacent protein-coding gene, including 48 with a correlation of |ρ| > 
0.8 (Supplemental Table 5). 
 
Human lncRNA orthologues 
To extend the utility of this catalogue of mouse lncRNAs, we sought to identify 
potential orthologous human lncRNAs by comparing the mouse genes to lncRNAs 
previously identified in human B cells17,33-35. Based on pairwise genomic alignments 
we identified 185 mouse lncRNAs that have a human syntenic orthologue 
(Supplemental Table 6). Taking advantage of the fact that eRNAs are a distinct class 
of lncRNA throughout B cell development (Supplemental Figure 6D) we compared 
mouse eRNAs with human eRNAs reported in CD19+ B cells34. Pairing eRNAs 
adjacent to orthologous human and mouse coding genes identified a further 228 
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mouse eRNAs that have one or more human eRNA counterparts (Supplemental 
Table 6). Such conserved location indicates that the human/mouse pairs may be 
marking enhancers of orthologous coding genes. 
 
PAX5 regulates lncRNA expression during normal and malignant B cell 
development 
The transcription factor PAX5 is expressed throughout B cell development and is 
crucial for commitment to the B cell lineage as well as for maintaining B cell 
homeostasis19,36. PAX5 mediates these functions through the regulation of protein-
coding gene expression, but it may also regulate lncRNA expression. Using 
previously published PAX5 binding sites36, we identified 784 and 717 lncRNAs in pro-
B cells and mature B cells, respectively, whose loci either overlapped, or were <1 kb 
downstream of a PAX5 binding site that had no comparable association with a 
protein-coding gene. This represented a statistically significant enrichment compared 
to a null model of PAX5 binding (pro-B cells: 6.1-fold, p < 10-4, mature B cells: 10.5-
fold, p < 10-4). Using published RNA-seq data for wild-type or Pax5-deficient pro-B 
cells or mature B cells36, we further identified 28 and 87 of these lncRNA loci, 
respectively, for which there is evidence that PAX5 both binds and regulates their 
expression (Supplemental Figure 10A-D, Supplemental Table 7). 
 
Disruption of PAX5 binding during early B cell development is associated with 
development of B-progenitor acute lymphoblastic leukemia (B-ALL)37. For this reason 
we extended our analysis of PAX5 binding and lncRNA expression using RNA-seq 
data from a mouse model of B-ALL in which Pax5 expression can be regulated by 
doxycycline38. Induction of Pax5 expression within leukemic cells causes the tumor 
cells to differentiate and the leukemia to regress. Comparison of B-ALL cells with and 
without doxycycline-induced Pax5 expression revealed 331 differentially expressed 
lncRNAs (q < 0.05), of which a large majority (91%) were up-regulated as a result of 
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Pax5 expression (Supplemental Table 7). Furthermore, most (184) of these lncRNAs 
originated from loci bound by PAX5 in pro-B cells, or mature B cells (Figure 5A,B). As 
an example, we show two previously annotated lncRNA loci (LNCGme00432 and 
LNCGme00344) together with a novel locus (LNCGme00345), all of which are 
eRNAs, and are bound by PAX5, differentially expressed in the absence of PAX5, 
and lie downstream of the B cell lymphoma 11a gene (Bcl11a) whose expression is 
also PAX5-dependent in B-ALL cells (Figure 5C). We note that Bcl11a does not have 
PAX5 binding sites near its TSS, and yet its expression is PAX5-dependent. Taking 
these observations together, we hypothesize that LNCGme00432, LNCGme00344 
and LNCGme00345 may be transcribed from PAX5-induced enhancers that in turn 
regulate expression of Bcl11a and thus explain how expression of Bcl11a is indirectly 
PAX5-dependent. Since BCL11A has been proposed to activate expression of the 
Rag1 and Rag2 genes and hence to promote VDJ recombination39, it may contribute 
to PAX5-dependent differentiation of B-ALL cells and subsequent regression of the 
leukemia. Furthermore, BCL11A is essential for B cell development40,41, and thus 
these lncRNAs may also mediate the effect of PAX5 on expression of Bcl11a during 
normal B cell development. Interestingly, LNCGme00344 and LNCGme00345 have 
human eRNA orthologues (BMThy_chr2_0943 and BMThy_chr2_0945, 
Supplemental Table 6), suggesting that this transcriptional regulation may be 
conserved in human B cells. In total we report 199 lncRNAs (including 73 eRNAs) 
that are bound by PAX5, show PAX5-dependent expression, and are neighboring a 




To aid in the identification of lncRNAs active within the immune system, we present a 
comprehensive catalogue of 4516 lncRNAs, including 2349 intergenic loci, expressed 
across 11 murine B cell populations. Translating genome-scale lncRNA identification 
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into in vivo functional studies remains a major challenge that necessitates the use of 
model organisms. Previous work has identified lncRNAs expressed in a subset of 
these populations in humans17,33-35. However, given the high tissue-specificity and 
rapid evolution of lncRNAs, a murine catalogue is therefore a prerequisite to 
successful lncRNA studies in the mouse. In addition, we defined patterns of 
expression, chromatin modification, and transcription factor binding that provide 
insight into the regulation and function of these transcripts, and we identified a subset 
of lncRNAs that have human orthologues and thus are of direct relevance to human 
research. 
 
The majority (67%) of lncRNA loci present in our catalogue contained no evidence of 
splicing. While single-exon transcripts had to be replicated in two or more samples to 
be included in this catalogue, their loci were less likely to be in published datasets. 
However, the high rate of PCR validation of these single-exon lncRNAs (85%) and 
their comparable intersection with clearly defined chromatin peaks confirms the 
reliability of the transcript annotation, and the demonstrated functions of single-exon 
lncRNAs such as NEAT142 and Paupar43 highlight the importance of including these 
transcripts in the catalogue. 
 
LncRNA genomic locations have the potential to provide insight into function. A 
substantial proportion of multi-exon (48%) and single-exon (48%) loci were antisense 
to or flanking (<5kb) protein-coding genes. Previous studies have classified as many 
as 60% of detected lncRNAs as antisense transcripts arising from bidirectional 
transcription at protein-coding promoters44, that could regulate expression of genes 
encoding transcriptional regulators45. These are included within the lncRNAs 
classified as flanking in this study. Full-length antisense lncRNAs have also been 
implicated in a variety of cellular functions46,47, most notably FAS-AS1, which 
regulates alternative splicing in its antisense coding gene Fas5,48. 




Half of all lncRNAs detected in B cells (52%) were intergenic (>5kb from a protein-
coding gene). The use of H3K4me1 and H3K4me3 chromatin marks to distinguish 
eRNAs from pRNAs has been previously demonstrated8, and we were able to 
corroborate many of the features of these transcripts. The consistent classification of 
these loci across B cell development strongly suggests that these markers identify 
two distinct and mutually exclusive classes of lncRNA. 
 
Comparison with lncRNAs expressed in human B cells identified 185 mouse 
lncRNAs that had a human orthologue, and a further 228 mouse eRNAs that have 
human eRNA counterparts. This offers the possibility of using the power of mouse 
genetics to study the in vivo function of these human lncRNAs by genetic 
modification of the corresponding mouse genes. 
 
The use of expression correlation as a means of associating lncRNA function with 
that of protein-coding genes has been successfully demonstrated in previous 
studies17,18. By clustering protein-coding genes on the basis of co-expression, we 
were able to identify discrete groups whose patterns of expression transcend 
individual B cell populations and whose members are associated with, for example, 
cell cycle function. Post hoc association of lncRNAs with these clusters implicated a 
substantial proportion (22%) of the lncRNAs with these specific processes. In 
addition this analysis supported the hypothesis that eRNAs may function to regulate 
expression of adjacent protein-coding genes7. 
 
Using external data we identified loci regulated by PAX5, a crucial mediator of B cell 
development, whose loss contributes critically to the development of B-ALL38. After 
incorporating our classification of lncRNAs based on chromatin state, we identified 73 
eRNAs situated proximal to protein-coding genes that also show Pax5-dependent 
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expression in B-ALL cells. The roles of such transcripts remain to be investigated; 
however, their discovery demonstrates the utility of our catalogue when used in 
conjunction with external datasets to probe the complexities of B cell development 
and disease. 
 
In conclusion, RNA-seq followed by de novo transcript assembly, has the potential to 
identify thousands of novel long non-coding transcripts. While a growing number of 
these transcripts have been assigned to diverse cellular processes, as yet, the 
majority have no known function. Given the large numbers of these transcripts, a 
major challenge when seeking to identify and characterize lncRNA function lies in the 
prioritization of plausible candidates for in vivo functional studies. We anticipate that 
this catalogue will serve as a valuable resource for such future research, for example 
by allowing systematic genetic screens of high-confidence lncRNAs to identify those 
with key functions in B cell development and activation. 
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Figure 1. Identification of lncRNAs expressed in B cells. (A) Schematic 
representation of the ontogenetic relationships between B cell populations used to 
generate the lncRNA catalogue. Solid arrows indicate developmental progression 
through B cell stages or activation (to germinal center B cells). Dashed line indicates 
recirculation of follicular B cells back to the bone marrow. Pro-B cells (PRO), pre-B 
cells (PRE), immature B cells (IMM), mature B cells (MAT), follicular B cells (FO), 
marginal zone B cells (MZ), germinal center B cells (GC), B1a B cells (B1A). (B) 
Genomic distribution of the 1491 multi-exon and 3025 single-exon lncRNAs identified 
by this study. Positions are described relative to ENSEMBL v72 protein-coding gene 
annotations as antisense (overlapping a coding gene on antisense strand), flanking 
(< 5 kb from coding gene) and intergenic (> 5 kb from coding gene). (C) Overlap 
between the 2349 intergenic lncRNAs identified by this study (B Cell), with those 
identified in T lineage cells18 (T Cell), and those annotated in Ensembl v78. (D, E) 
Kernel density plots representing the distribution of distance between each multi-
exon (D) and single-exon (E) intergenic lncRNA TSS and the nearest annotated TSS 
on the same strand that appeared in two or more of the 128 mouse cell lines 
considered by the FANTOM5 consortium. Shaded regions indicate a null distribution 
as measured by distance to the nearest FANTOM5 annotated TSS on the opposing 
strand. Grey vertical dashed line indicates a distance of 500bp. (F) Coverage of the 
genome and of lncRNA exons by the indicated transposon elements. 
 
Figure 2. Identification of intergenic lncRNAs with enhancer-like and promoter-
like characteristics. (A, B) Examples of intergenic lncRNA loci with chromatin 
signatures in marginal zone B cells that are characteristic of (A) enhancer-like RNA 
(eRNA) loci (LNCGme01103), and (B) promoter-like (pRNA) loci (LNCGme01293). 
The former are distinguished by high H3K4me1 read coverage across the TSS and 
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the absence of a corresponding H3K4me3 peak. The latter are distinguished by high 
H3K4me3 coverage, the presence of which excludes H3K4me1 from the TSS. Also 
shown in (B) is a second lncRNA (LNCGme01244) that arises as a result of bi-
directional transcription from the Scyl1 promoter, but this is not classified as an eRNA 
or pRNA due to its proximity to a coding gene. (C) The proportion of the 2349 
intergenic lncRNAs identified in this study that could be classified as either eRNAs or 
pRNAs on the basis of their chromatin state. Remaining lncRNAs are either classified 
as unassigned (insufficient read coverage/fold-change to determine chromatin state) 
or conflicted (classified as eRNA in one B cell stage and pRNA in another). (D) The 
proportion of eRNA and pRNA loci that are classified as multi-exon or single-exon. 
(E) Pairwise comparisons showing the consistency of chromatin signatures across B 
cell populations. Within each B cell population intergenic lncRNAs are ranked on the 
ratio of H3K4me1:H3K4me3 coverage across their TSS. Individual plots show the 
local regression (loess) of rank order between two B cell populations. (F) Distribution 
of the Pearson’s correlation coefficient between the expression of an eRNA or pRNA 
and expression of the more highly correlated of either its nearest upstream or 
downstream protein-coding gene. (G) Distribution of median expression values (rlog-
transformed read counts) calculated across all cell stages. (H) Distribution of cell-
stage specificity of expression of eRNAs and pRNAs. (***Mann-Whitney U test: p < 
0.0001). 
 
Figure 3. Cell-stage specific expression at lncRNA and protein-coding loci. 
Principal component analysis of regularized log-transformed expression patterns at 
(A) protein-coding loci and (B) the 4516 lncRNA loci identified in this study. Grey 
dashed lines indicate groups identified by unsupervised hierarchical clustering 
(Supplemental Figure 7A, B). (C) Box plots of specificity of expression of all coding 
and lncRNA loci separated into quartile bins on the basis of their median expression 
across all eight B cell stages. Numbers below each quartile indicate the number of 
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lncRNA and protein-coding loci that fall into each category. (D, E) Venn diagrams 
showing the number of protein-coding (D) and lncRNA (E) loci that are either 
expressed in multiple cell populations (blue) or expressed in a single cell population 
(red) at an FPKM threshold of 1.0. Splenic plasmablasts (PB) and plasma cells 
(PC(SP)), and bone marrow plasma cells (PC(BM)). Numbers adjacent to each plot 
depict the proportion of loci falling into each category.  
 
Figure 4. Association between lncRNAs and protein-coding genes based on 
correlation of expression across B cell development. (A) Weighted gene co-
expression network analysis (WGCNA) identifies clusters of protein-coding genes 
with comparable expression profiles across B cell development: plots show a 
representative expression profile (eigengene) for each of 10 protein-coding gene 
clusters. (B) Stacked bar charts showing the number of lncRNAs whose expression 
is strongly correlated (|ρ| > 0.8) with the adjacent eigengene. Colors depict lncRNA 
classification on the basis of chromatin state. (Results are shown for WGCNA 
clusters with >10 associated lncRNAs.) (C) Heat map showing the normalized 
expression of cluster lightpink4 containing 31 protein-coding genes identified as 
upregulated or downregulated in marginal zone B cells. (D) The normalized 
expression profile of a single gene (Zc3h12c) from this cluster identified as 
upregulated in marginal zone B cells and a single eRNA (LNCGme02323) identified 
as strongly correlated with the respective WGCNA cluster. (E) Genome plots 
showing the location of Zc3h12c and LNCGme02323, as well as H3K4me1 and 
H3K4me3 chromatin signatures in marginal zone B cells, and RNA-seq read 
coverage in all 8 B cell populations considered in this study.  
 
Figure 5. Identification of lncRNAs with PAX5-dependent expression in B-ALL 
cells. (A) Venn diagram depicting overlap between lncRNAs with sufficient read 
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coverage to be included in this analysis (black), lncRNAs differentially expressed 
(DE) between B-ALL cells with and without doxycycline-induced Pax5 expression 
(red), and PAX5 transcription factor binding sites (TFBS) annotated in either pro-B 
cells or mature B cells (blue) that could not be associated with a protein-coding gene. 
A subset of lncRNAs is both differentially expressed and has PAX5 bound within the 
gene body or promoter region (gold). (B) Volcano plot depicting the fold-change in 
lncRNA expression between B-ALL cells versus B-ALL cells with doxycycline-
induced Pax5 expression (see Supplemental Table 7) plotted against the probability 
that this difference had occurred by chance (q-value). Each dot represents a single 
lncRNA and is colored black unless it was differentially expressed (q < 0.05) and 
either near or not near a PAX5 binding site (gold or red respectively). (C) Genome 
plot showing PAX5-bound eRNA loci (LNCGme00432, LNCGme00344 and 
LNCGme00345), together with their proximal protein-coding gene, the zinc-finger 
protein gene B cell lymphoma 11a (Bcl11a). All are differentially expressed in B-ALL 
cells upon induction of Pax5 expression. PAX5 binding sites in Pro-B cells are 
indicated in gold. The other annotated lncRNA (LNCGme00346) is also an eRNA that 
is differentially expressed on induction of Pax5 expression, but it shows no evidence 
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